For both trials in early RA patients, an improvement in DAS28(CRP) of 45% had the most discriminatory ability for both the lowest P value and greatest difference between the ADA+MTX and PBO+MTX at week 24 (Fig. 4a, b and Additional file 1: Table S1). Here, CRP is linked to rheumatoid arthritis.